-
[show abstract]
[hide abstract]
ABSTRACT: The inverted-T skin-reducing mastectomy with implant reconstruction represents a very effective reconstructive and cosmetic option in patients with macromastia. However, in this subset of patients, the risk of skin flap necrosis, especially at the T-junction, is significant. In this setting, complete implant coverage with viable tissue beneath the mastectomy skin flaps is essential to reduce morbidity. In this article, the authors retrospectively review their series of 16 skin-reducing mastectomy and immediate one-stage implant reconstructions using the submuscular-subfascial pocket, analyzing the reconstructive issues and cosmetic outcomes.
Between June of 2008 and August of 2010, 14 women underwent skin-reducing mastectomy with immediate implant reconstruction using definitive anatomical gel implants, totalling 16 breasts. Reconstructive evaluation methods were clinically and photography-based assessment. The BREAST-Q was used to quantify patient satisfaction.
The average follow-up time was 18.6 months (range, 6 to 36 months). The average implant volume was 416.5 cc (range, 300 to 500 cc). The reconstructive outcomes were excellent to good, with patient satisfaction ranking high to very high, except in two patients who experienced skin necrosis (14.3 percent).
The authors' series suggests that skin-reducing mastectomy with immediate implant reconstruction can be easily and safely performed when an appropriate conservative skin-reducing mastectomy pattern is designed, providing complete autologous implant coverage with the submuscular-subfascial pocket. However, further studies are needed to enhance patient selection and reduce the complication rate.
Therapeutic, IV.
Plastic and reconstructive surgery 07/2012; 130(1):31-41. · 2.74 Impact Factor
-
Luigia Nardone,
Vincenzo Valentini,
Lorenza Marino,
Maria Carmen De Santis, Daniela Terribile,
Gianluca Franceschini,
Mario Balducci,
Giovanna Mantini,
Giancarlo Mattiucci,
Antonino Mulè,
Paolo Belli,
Riccardo Masetti
[show abstract]
[hide abstract]
ABSTRACT: The aim of the study was to evaluate the feasibility of neoadjuvant low-dose fractionated radiotherapy, in combination with two anthracycline-docetaxel regimens, in breast cancer treatment.
Women with stage IIA/B-IIIA breast cancer were assigned to receive the treatment of low-dose fractionated radiotherapy (0.4 Gy/per fraction, 2 fractions per day, for 2 days, every 21 days for 8-6 cycles) with concomitant neoadjuvant chemotherapy with non-pegylated liposomal doxorubicin and docetaxel. Two chemotherapy schedules were planned to be combined with low-dose fractionated radiotherapy. The first schedule consisted of four cycles of non-pegylated liposomal doxorubicin sequentially followed by four cycles of docetaxel, and the second schedule consisted of six cycles of non-pegylated liposomal doxorubicin plus concomitant docetaxel. Acute toxicity was evaluated according to the Radiation Therapy Oncology Group score system. Pathological response was evaluated by the Mandard score and expressed as tumor regression grade.
Between March 2008 and February 2009, 10 patients underwent low-dose fractionated radiotherapy and concomitant chemotherapy. No grade 3-4 breast toxicity was observed. Five patients had a clinical complete response. Seven patients underwent conservative surgery. Overall, tumor regression grade 1 (absence of residual cancer) was achieved in one patient (10%) and grade 2 (residual isolated cells scattered through the fibrosis) in 4 patients (40%). The pathologic major response rate (tumor regression grade 1 + 2) was 20% in patients receiving low-dose fractionated radiotherapy and sequential non-pegylated liposomal doxorubicin and docetaxel and 80% in the group receiving low-dose fractionated radiotherapy and concurrent non-pegylated liposomal doxorubicin and docetaxel treatment.
Concomitant low-dose fractionated radiotherapy combined with anthracycline and docetaxel is feasible. The toxicity profile of radio-chemotherapy was similar to that of chemotherapy alone: there was no acute skin or cardiac toxicity. The concurrent application of liposomal doxorubicin and docetaxel with low-dose fractionated radiation led to higher histological response rates compared to the sequential application of the same two drugs.
Tumori. 01/2012; 98(1):79-85.
-
[show abstract]
[hide abstract]
ABSTRACT: The aim of this study was to investigate the role of diffusion imaging in the evaluation of response to neoadjuvant breast cancer treatment by correlating apparent diffusion coefficient (ADC) value changes with pathological response. From June 2007 to June 2009, all consecutive patients with histopathologically confirmed breast cancer undergoing neoadjuvant chemotherapy were enrolled. All patients underwent magnetic resonance imaging (MRI) (including diffusion sequence) before and after neoadjuvant treatment. The ADC values obtained using two different methods of region of interest (ROI) placement before and after treatment were compared with MRI response (assessed using RECIST 1.1 criteria) and pathological response (assessed using Mandard's classification). Fifty-one women (mean age 48.41 years) were included in this study. Morphological MRI (RECIST classification) well evaluated the responder status after chemotherapy (TRG class; area-under-the-curve 0.865). Mean pretreatment ADC values obtained with the two different methods of ROI placement were 1.11 and 1.02 × 10(-3) mm(2) /seconds. Mean post-treatment ADC values were 1.40 and 1.35 × 10(-3) mm(2) /seconds, respectively. A significant inverse correlation between mean ADC increase and Mandard's classifications was observed for both the methods of ADC measurements. Diagnostic performance analysis revealed that the single ROI method has a superior diagnostic accuracy compared with the multiple ROIs method (accuracy: 82% versus 74%). The coupling of the diffusion imaging with the established morphological MRI provides superior evaluation of response to neoadjuvant chemotherapy treatment in breast cancer patients compared with morphological MRI alone. There is a potential in the future to optimize patient therapy on the basis of ADC value changes. Additional works are needed to determine whether these preliminary observed changes in tumor diffusion are a universal response to tumor cell death, and to more fully delineate the ability of ADC value changes in early recognizing responder from nonresponder patients.
The Breast Journal 09/2011; 17(6):610-9. · 1.64 Impact Factor
-
[show abstract]
[hide abstract]
ABSTRACT: Immediate breast reconstruction after skin and nipple-sparing mastectomies is commonly performed as a two-stage procedure; to overcome the paradox of traditional two-stage tissue expander/implant reconstruction used to create a tight muscular pocket that needs expansion to produce lower pole fullness, while losing the laxity of the mastectomy skin flaps, the authors conceived a subpectoral-subfascial pocket by elevating the major pectoral muscle in continuity with the superficial pectoralis fascia up to the inframammary fold. This alteration allowed for the immediate insertion of the definitive implant. The authors present their experience in 220 cases of immediate one-stage breast reconstructions with definitive prostheses in sparing mastectomies. Immediate and long-term local complications were evaluated. Immediate breast reconstruction with definitive anatomical silicone-filled implants can produce excellent cosmetic results (78.6%) with a low rate of complications (17.7%); these results allow for agreement between oncologic, aesthetic and economic purposes.
Breast (Edinburgh, Scotland) 02/2011; 20(1):7-14. · 2.09 Impact Factor
-
Gianluca Franceschini, Daniela Terribile,
Ilaria Scafetta,
Stefano Magno,
Cristina Fabbri,
Federica Chiesa,
Alba Di Leone,
Francesca Moschella,
Assunta Scaldaferri,
Simona Fragomeni,
Valerio Vellone,
Antonio Mulè,
Riccardo Masetti
[show abstract]
[hide abstract]
ABSTRACT: Adenoid cystic carcinoma of the breast is a rare neoplasm accounting for 0.1% of all malignant breast tumors and presenting most commonly as a painful breast mass. Compared with the more common histological forms of breast cancer, it has a more favorable prognosis and lymph node involvement or distant metastases seldom occur.
A unique case of multifocal adenoid cystic carcinoma of the breast presenting as a painful and well-defined lump and treated with conservative surgery with adjuvant radiotherapy is reported.
There is no consensus on the optimal management of this disease. A breast-conserving approach may be recommended even if mastectomy has been traditionally the treatment of choice. Chemotherapy, radiation, and hormonal therapy have been infrequently used and so far have had no defined role in this kind of neoplasm. The authors found no other reports in the literature focusing on a conservative approach to multifocal adenoid cystic carcinoma.
Medical science monitor: international medical journal of experimental and clinical research 02/2010; 16(3):CS33-39. · 1.70 Impact Factor
-
[show abstract]
[hide abstract]
ABSTRACT: nipple dichotomy (or intra-areolar polythelia) is a rare congenital malformation in which one or more supernumerary nipples are located within the same areola.A case of a woman undergoing a central quadrantectomy with a contralateral supernumerary nipple used for reconstruction is reported. No other report in the Literature, according to our search, has focused on reconstructive use of an accessory nipple after breast conserving surgery.
the patient is a 73 year-old Caucasian woman, who two years earlier underwent a lower-outer left Quadrantectomy plus axillary sampling and radiation therapy for a 2,2 cm lobular carcinoma with no lymph node involvement.A routine follow-up assessment showed an important fibrotic change on the operated breast, just across the infra-mammary fold; at a breast Magnetic Resonance Imaging, a 1,5 cm area in retroareolar position, suspicious for local recurrence, was evident.An open biopsy was therefore performed, under local anaesthesia, including the nipple-areolar complex to realize a central Quadrantectomy with a Grisotti procedure; a congenital dichotomic nipple in the contralateral breast was then used to repair the defect through a "nipple-sharing" technique. The final histological examination reported a fibrotic mastopathy without atypias.
in this case, the "nipple-sharing" technique has allowed in the same time the correction of a rare congenital defect and provided the surgeon with a supernumerary nipple to be used in the immediate reconstruction after breast conserving surgery.
Cases Journal 02/2009; 2(1):32.
-
[show abstract]
[hide abstract]
ABSTRACT: Lactating adenoma is a benign condition, representing the most prevalent breast lesion in pregnant women and during puerperium; in this paper, a case of a woman with lactating adenoma occurring during the first trimester of pregnancy is reported. There have been no reports in the literature, according to our search, focusing on magnetic resonance imaging findings in cases of lactating adenomas. Also the early onset of the lesion during the first trimester of pregnancy is quite unusual and possibly unique.
We report the case of a primiparous 30-year-old Caucasian woman, who noted an asymptomatic lump within her left breast during the 9th week of gestation, slightly increasing in size over the next few weeks. Ultrasound demonstrated a hypoecoic solid mass, hypervascularized and measuring 4 cm. On magnetic resonance imaging, performed in the first month after delivery, the lesion appeared as an ovoidal homogeneous mass, with regular margins and a significant contrast enhancement indicative of a giant adenoma.
Magnetic resonance imaging could play an important role in the differential diagnosis of pregnancy-related breast lumps, particularly during puerperium, thus avoiding unnecessary surgical biopsies.
Journal of Medical Case Reports 02/2009; 3:43.
-
The Breast Journal 01/2009; 15(1):105-6. · 1.64 Impact Factor
-
Lucio Fortunato,
Marcello Santoni,
Stefano Drago,
Giacomo Gucciardo,
Massimo Farina,
Claudio Cesarini,
Alessandro Cabassi,
Claudio Tirelli, Daniela Terribile,
Gian Battista Grassi,
Smeralda De Fazio,
Carlo Eugenio Vitelli
[show abstract]
[hide abstract]
ABSTRACT: The role of sentinel lymph node biopsy (SLNB) in pT1a and "microinvasive" breast cancer has not been extensively studied. We report our experience with SLNB in patients with "minimal" breast cancer to determine the incidence and type of SLN metastases, and to study the potential impact on their surgical or oncological management. Among some 3387 women operated upon for primary breast cancer who underwent sentinel lymph node biopsy at nine institutions participating in the Rome Breast Cancer Study Group, 251 were staged pT1a or pT1mic (7.4%). There were 13 cases of sentinel lymph node metastases identified in this group of patients (5.2%), seven macrometastases and six micrometastases. Additionally, ITC were diagnosed by immunohistochemistry in four cases (1.6%). The incidence of SLN metastases was 7/174 (4%) and 6/77 (7.8%) in patients with pT1a and pT1mic tumors, respectively (p=0.2). Age and histological grade were predictive factors for SLN metastases. Chemotherapy was seldom directed by axillary node status (8/38 patients). As the incidence of SLN metastases in these patients is very small, particularly in the pT1a group, the indications for even a minimally invasive procedure, such as sentinel lymph node biopsy, should be probably individualized.
The Breast 06/2008; 17(4):395-400. · 2.49 Impact Factor
-
[show abstract]
[hide abstract]
ABSTRACT: Breast cancer remains the most common malignancy and the leading cause of cancer death in women of all ages. The American Cancer Society has estimated that 180,200 women will develop breast cancer in the United States in 1997 and 43,900 will die from the disease (1). Age is an important variable affecting both breast cancer biology and management. The risk of developing breast cancer increases with age. Feuer et al., using data from the National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) Program, have estimated that the cumulative probability of developing invasive breast cancer from birth, which is less than 0.5% at the age of 40, increases approximately 20-fold for those women that reach the age of 95 years (2).As the duration of life continues to increase in the western world, the percentage of older women who have breast cancer will also increase. It is estimated that by the end of the 20th century more than 50% of all new cases of breast cancer will occur in women aged 65 years or older (3).Despite this high prevalence of disease, there is a great lack of definitive information about outcome from breast cancer in this segment of the population. Patients over the age of 65 years have frequently been excluded from large prospective randomized clinical trials, and as a consequence, no clear practice guidelines about the optimal management of these patients have been released.Many studies have indicated that elderly women with breast cancer are more likely to receive less aggressive treatment when compared to their younger counterparts (4–6). This lesser treatment has stemmed from several widely held assumptions: that older women (a) have less aggressive breast cancers, (b) have a greater likelihood of presenting with more advanced disease, (c) have a life expectancy so limited not to justify the use of standard treatment, and (d) are poor candidates for surgery more extensive than biopsy and for adjuvant treatments. Evidence to support these assumptions remains controversial.This article will provide an overview of available data on the main unresolved issues, including biology, screening, local treatment, and adjuvant therapy, and will try to indicate practice guidelines for the management of elderly women based on the current knowledge.
The Breast Journal 01/2003; 4(1):55 - 61. · 1.64 Impact Factor
-
[show abstract]
[hide abstract]
ABSTRACT: As screening mammography has become more frequently used to screen asvmptomatic women, the diagnosis of ductal carcrinoma in situ (DCIS) has become commonplace. Its treatment remains contentious, ranging from mastectomy to local excision alone. The goal of treatment for DCIS is breast conservation, however, as many as 25% of women with this diagnosis may require mastectomy. Although no clear selection criteria have been adopted to subdivide patients into groups best treated by either mastectomy or local excision with or without radiation therapy, many patients with DCIS are candidates for local excision alone, if the biology of the disease is favorable, the size is small, and the margins are negative. Radiation therapy added to local excision decreases the likelihood of recurrence; however, if there is recurrence when first radiation is employed, the patient's only remaining choice often is mastectomy.
Obstetrics and Gynecology Clinics of North America 04/2002; 29(1):189-200, viii-ix. · 1.70 Impact Factor
-
[show abstract]
[hide abstract]
ABSTRACT: The typical presentation of breast cancer in a young woman is discussed. Diagnostic imaging of the breast showed the presence of an extensive pathological area, approximately 5 cm in size, at the level of the upper quadrants of left breast. On mammography the pathological sign was represented by numerous regional granular microcalcifications. On sonography an inhomogeneously hypoechoic area with intralesional hyperechoic spots was identified. On MRI a large area of pathological enhancement was visualized. For the tumor extent and the patient's young age neoadjuvant chemotherapy was performed. Post-treatment assessment showed good response to therapy, suggestive of possible better prognosis.
Rays 30(3):239-44.
-
Lucio Fortunato,
Stefano Drago,
Carlo Eugenio Vitelli,
Marcello Santoni,
Giacomo Gucciardo,
Alessandro Cabassi,
Massimo Farina,
Massimo La Pinta,
Massimiliano Remedi,
Giovanni Pagano,
Teresa Silipod, Daniela Terribile,
Daniela Stagnitto,
Giovanni Battista Grassi
[show abstract]
[hide abstract]
ABSTRACT: We report our multicentric experience with sentinel lymph node biopsy for breast cancer patients. Patients with breast cancer operated on from January 1999 to March 2005 in 6 different institutions in the Rome area were retrospectively reviewed. All patients gave written informed consent. 1440 consecutive patients were analysed, with a median age of 59 years (range: 33-81) and a median tumour diameter of 1.3 cm (range: 0.1-5). Patients underwent lymphatic mapping with Tc99 nanocolloid (N = 701; 49%), with Evans Blue (N = 70; 5%), or with a combined injection (N = 669, 46%). The majority of patients were mapped with an intradermal or subdermal injection (N = 1193; 84%), while an intraparenchymal or peritumoral injection was used in 41 (3%) and 206 patients (13%), respectively. Sentinel lymph nodes were identified in 1374/1440 cases (95.4%), and 2075 sentinel lymph nodes were analysed (average 1.5/patient). A total of 9305 additional non-sentinel lymph-nodes were removed (median 6/patient). Correlations between sentinel lymph nodes and final lymph node status were found in 1355/1374 cases (98.6%). There were 19 false-negative cases (5%). Lymph node metastases were diagnosed in 325 patients (24%). In this group, micrometastases (< 2 mm in diameter) were diagnosed in 103 cases (7.6%). Additionally, isolated tumour cells were reported in 61 patients (4,5%). In positive cases, additional metastases in non-sentinel lymph-nodes were identified in 117/325 cases after axillary dissection (36%). Axillary dissection was avoided in 745/1440 patients (52%). At a median follow-up of 36 months, only 1 axillary recurrence has been reported. Sentinel lymph node biopsy improves staging in women with breast cancer because it is accurate and reproducible, and allows detection of micrometastases and isolated tumour cells that would otherwise be missed. Our multicentric study confirms that this is the preferred axillary staging procedure in women with breast cancer.
Chirurgia italiana 58(6):689-96.
-
[show abstract]
[hide abstract]
ABSTRACT: Although the surgical treatment of breast cancer has become more conservative in the last decades, some patients still arrive at the first physical examination with advanced diseases and with large skin infiltration. We report an unusual case of giant invasive papillary carcinoma of the breast underwent mastectomy and reconstruction with a bipedicled transverse rectus abdominis myocutaneous (TRAM) flap.
Annali italiani di chirurgia 77(4):341-4. · 0.23 Impact Factor
-
[show abstract]
[hide abstract]
ABSTRACT: Over a ten-year period a series of 350 nonpalpable breast lesions were examined to evaluate the positive predictive value of malignancy of the different mammographic findings and the incidence of carcinoma in situ in the different categories. Lesions were separated into opacities and microcalcifications. Surgical biopsy revealed the presence of carcinoma in 190 of 350 lesions with an overall PPV of 54% and a B/M ratio of 0.84. Within opacities, the PPV was 80.2% for spiculate opacities, 53.8% for irregular opacities, 34.7% for opacities with calcifications and 17.4% for parenchymal distortions. As many as 151 of 350 (46%) lesions were shown to be isolated microcalcifications on mammography with an overall PPV of 46% and a B/M ratio of 0.92. 42 of 80 malignant lesions were shown to be ductal carcinomas in situ (50%). According to data of the literature PPV for Le Gal and BI-RADS class 5 was 92% and 86.27%, respectively. Le Gal classification of microcalcifications intends to describe a sign with which a risk of malignancy is associated. In BI-RADS categorization the sign plays a prognostic role and for each class a diagnosticotherapeutic approach is suggested. Therefore a correct BI-RADS categorization can be of support for both radiologists and clinicians in the patient management.
Rays 27(4):233-9.
-
[show abstract]
[hide abstract]
ABSTRACT: The sensitivity, specificity and accuracy of MRI in detecting breast cancer recurrence were analyzed. 40 patients undergoing breast conserving therapy were studied with MRI. Cytohistologic examinations of suspected local recurrence were carried out. In these patients, the clinical, mammographic and sonographic characteristics of local recurrence were nonspecific or dubious. All patients were examined at least 1 year after completion of radiation therapy. Qualitative and quantitative information was acquired with dynamic MRI. Statistical analysis was performed with the Student's t test. Breast cancer recurrence identified in 22 patients was confirmed on histology in all of them. There were only 2 cases of false positive results. MRI showed 95% accuracy, 100% sensitivity and 88.8% specificity with 5% false-positives and 100% negative predictive value. Dynamic MRI appears a valuable technique for differentiation of post-treatment changes in recurrent carcinoma and for guiding the histological confirmation.
Rays 27(4):241-57.
-
[show abstract]
[hide abstract]
ABSTRACT: The study was carried out to evaluate the response to preoperative chemotherapy of locally advanced breast cancer with MRI. The series included 45 women with locally advanced breast cancer who underwent MRI before and after neoadjuvant chemotherapy. Based on the volume of residual disease, the response to chemotherapy was classified as: complete response, partial response, minor response, no change and disease progression. Responses to neoadjuvant chemotherapy were compared to MRI findings and to prognostic factors. Based on MRI findings 8 patients were assigned to the complete response group, 16 to the partial response group, 11 to the minor response group, 9 to the no change group and 1 patient to the disease progression group. MRI showed 90.2% sensitivity, 100% specificity and 91.1% accuracy. The correlation between MRI findings and prognostic factors may be useful to predict cancer aggressiveness and to understand the natural history of different breast carcinomas.
Rays 27(4):279-90.
-
[show abstract]
[hide abstract]
ABSTRACT: The treatment of breast cancer has undergone continuous and profound changes over the last three decades; breast conservation therapy has been progressively validated as a safe alternative to radical mastectomy for patients with early stage breast cancer. Several large trials have shown that overall survival time of patients treated with conservative surgery and axillary dissection followed by radiation therapy is equivalent to that of patients treated with modified radical mastectomy, with better cosmetic outcomes and acceptable rates of local recurrence. Improvements in diagnostic work-up and the wider diffusion of screening programs have allowed the detection of smaller, often non palpable tumours, furtherly facilitating the widespread use of tumour localization and breast conserving techniques. Since the removal of negative lymph nodes is useless, eventually harmful and plays no therapeutic role in breast cancer patients, techniques for staging of the axilla have also gradually evolved toward less aggressive approaches, such as lymphatic mapping and sentinel node biopsy. The introduction of "onco-plastic techniques", that combine the concepts of oncological and plastic surgery of the breast, achieve the goal of allowing more extensive excisions while improving the aesthetic results, and eventually patient's quality of life. The present work will highlight potential benefits as well as unresolved issues of the above mentioned therapeutic options, with special emphasis on technical aspects of conservative surgery in the treatment of early breast cancers.
Annali italiani di chirurgia 79(1):17-22. · 0.23 Impact Factor
-
[show abstract]
[hide abstract]
ABSTRACT: The natural history and survival of breast cancer are extremely variable although the advances and improvement in treatment in recent years led to a lower mortality. In fact, in spite of the administration of systemic adjuvant therapy, women with metastatic lymph nodes at diagnosis have a risk of disease progression at 5 years of 40-50%. The disease heterogeneity and the intrinsic tumor cell resistance to therapies are determining factors of the problem. The role of parameters as tumor size, grading, vascular spread, axillary lymph node status, are well defined. However the increasingly early diagnosis and changes in clinical practice have led to the need for non morphologic parameters as estrogen and progesteron receptors, cell proliferation index, labelling index, growth factors tumor-dependent genes (p53, HER2), cell cycle regulators (cyclins). Specific cellular and molecular alterations are studied to identify diagnosticoinstrumental images (MRI) of tumor angiogenesis, the cause of the different tumor aggressiveness. In the surgical and consequently clinico-oncologic approach there is the problem of the interpretation and prognostic role of sentinel lymph node when it is positive for micrometastasis only, if diagnosed by immunohistochemistry.
Rays 27(3):193-200.
-
[show abstract]
[hide abstract]
ABSTRACT: Conformal radiotherapy has improved the technique and favored the solution of the problem of limiting cardiac and pulmonary irradiation. However new uncertainties have arisen especially with regard to treatment reproducibility. Passing from the clinical concept of CTV to the geometric concept of PTV, the anatomic identification of the different structure becomes of major importance together with the knowledge of the clinical evolution of breast cancer. The irradiation of breast lymph nodes now requires, if possible, 3D conformal processing of the treatment. Treatment parameters should be selected as to ensure adequate irradiation of target volumes while sparing healthy tissues as much as possible. In a near future, IMRT should be able to markedly improve the dose homogeneity to target with consequent lower cardiopulmonary toxicity.
Rays 28(3):303-9.
